Venclexta (venetoclax)

About AbbVie

AbbVie Inc. is a research-based biopharmaceutical company formed in 2013 as a spinoff from Abbott Laboratories. The company focuses on developing and delivering innovative therapies that address some of the world's most complex and serious diseases. With a strong portfolio led by immunology treatments and a growing oncology franchise, AbbVie has established itself as a leader in specialty therapeutics with global operations and a commitment to advancing patient care.

Therapeutic Areas